Brief: Cereno Announces Extended Patent Protection In Europe For CS585 Program
April 9 (Reuters) - Cereno Scientific AB CRNOSb.ST :
* CERENO SCIENTIFIC ANNOUNCES EXTENDED PATENT PROTECTION IN
EUROPE
FOR CS585 PROGRAM
* PATENT EXPANDS PATENT PROTECTION FOR PROSTACYCLIN RECEPTOR
AGONIST PROGRAM TO ALSO INCLUDE EUROPE, ONE OF LARGEST MARKETS
FOR CARDIOVASCULAR DISEASE
Source text for Eikon: ID:nWkr7CDWgK
Further company coverage: CRNOSb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln